Nature's Sunshine

NATR

Market cap $479M

Nature's Sunshine is upgraded to Buy, driven by robust DTC growth and effective influencer marketing. NATR exceeded 2025 guidance with $480.1M revenue and $49.4M adjusted EBITDA, signaling operational outperformance. Guidance for 2026 targets $500–$515M revenue and $50–$54M EBITDA, supporting a $37.99 price target—56% above current levels.

Nature's Sunshine Products delivered Q4 results and 2026 guidance that exceeded analyst expectations, driving a post-market stock surge. NATR's revenue, profits, and adjusted profits all grew year-over-year, with notable strength in Europe and North America and robust cash holdings of $93.9 million. Management guides for 2026 revenue of $500–515 million and EBITDA of $50–54 million, with a long-term vision to reach $1 billion in revenue.

Nature's Sunshine Products, Inc. (NATR) Q4 2025 Earnings Call Transcript

LEHI, Utah, March 10, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine” and/or the “Company”), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2025.

Three consumer stocks are drawing fresh analyst attention this week as earnings season approaches.

LEHI, Utah, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (Nasdaq: NATR) (“Nature's Sunshine”) (the “Company”), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Tuesday, March 10, 2026, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the fourth quarter and full year ended December 31, 2025. The Company will report its financial results in a press release prior to the conference call.

Consumer confidence has dipped to multi-year lows, yet the coming fiscal stimulus could support consumer spending on essentials. While macro conditions remain mixed, staples' relative stability and essential nature make them compelling considerations for diversified portfolios. Investors looking for defensive exposure can consider opportunities not just in large cap staple giants, but in niche and value-oriented names poised to benefit from macro trends.

LEHI, Utah, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Synergy Worldwide, a division of Nature's Sunshine Products, today announced that Euromonitor International has named Pro-Argi-9+ the world's #1 l-arginine supplement,* reinforcing the product's growing global momentum and Synergy's leadership in the health and wellness space.

Mr. Fritz Brings Decades of Operational Excellence and Innovation to Support the Company's Global Supply Chain Mr. Fritz Brings Decades of Operational Excellence and Innovation to Support the Company's Global Supply Chain

Nature's Sunshine delivered strong Q3 2025 results, driven by robust growth in Asia and recurring autoship sales. NATR's international focus, especially in Asia and Europe, positions it for continued growth, though its MLM model may cause choppy performance. Despite a strong balance sheet, buybacks, and premium margins, NATR's current valuation reflects its strengths, and it trades at a premium to other MLMs.